Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2025-12-30 @ 12:48 PM
Study NCT ID:
NCT03323151
Status:
COMPLETED
Last Update Posted:
2024-01-18
First Post:
2017-10-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma
Sponsor:
PrECOG, LLC.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-13
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-07
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-16
First Submit QC Date:
None
Study First Post Date:
2017-10-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-08-30
Results First Submit QC Date:
None
Results First Post Date:
2024-01-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-16
Last Update Post Date:
2024-01-18
Last Update Post Date Type:
ACTUAL